Patent · US Active

Heterocyclic sulfonamide derivative and medicine containing same

US10584116B2 · kind B2 · utility

0Cited by
2References
19Claims
0Family size

Assignee

Inventors

Key dates

Filing dateAug 3, 2018
Grant dateMar 10, 2020
Priority date—
Expiry dateAug 3, 2038

Classification

  • Technology area (CPC C)Chemistry; Metallurgy
  • CPC primaryC07K14/705
  • WIPO fieldPharmaceuticals
  • WIPO sectorChemistry

Abstract

Compounds of represented by formula (I): wherein each symbol is defined herein and pharmaceutically acceptable salts thereof exhibit TRPA1 antagonist activity and are useful as TRPA1 antagonists and the prophylaxis or treatment of diseases involving TRPA1.

Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.